You are here

Article info

Article menu

Download PDFPDF

Commentary
Low-dose irradiation for reversing immunotherapy resistance: how to translate?

Authors

  • Maria Ochoa-de-Olza Ludwig Institute for Cancer Research Lausanne branch, Lausanne, SwitzerlandImmuno-oncology Service, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland PubMed articlesGoogle scholar articles
  • Jean Bourhis Radiation Oncology Service, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland PubMed articlesGoogle scholar articles
  • George Coukos Ludwig Institute for Cancer Research Lausanne branch, Lausanne, SwitzerlandImmuno-oncology Service, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland PubMed articlesGoogle scholar articles
  • Fernanda G Herrera Ludwig Institute for Cancer Research Lausanne branch, Lausanne, SwitzerlandImmuno-oncology Service, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, SwitzerlandRadiation Oncology Service, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland PubMed articlesGoogle scholar articles

Citation

Ochoa-de-Olza M, Bourhis J, Coukos G, et al
Low-dose irradiation for reversing immunotherapy resistance: how to translate?
Journal for ImmunoTherapy of Cancer 2022;10:e004939. doi: 10.1136/jitc-2022-004939
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.